Combining lymph node ratio to develop prognostic models for postoperative gastric neuroendocrine neoplasm patients

doi:10.4251/wjgo.v16.i8.3507

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-9)

Tables (1-2)

Sum=0

Aug 15, 2024 (publication date) through Aug 7, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3507-3520
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3507

Full Size Figure Download Figure

Figure 6 The 1-year, 3-year, and 5-year decision curve analysis curves for the American Joint Committee on Cancer tumor-node-metastasis staging, the Cox proportional hazards model, and the random survival forest model in the test set. A: The 1-year decision curve analysis (DCA) curves; B: The 3-year DCA curves; C: The 5-year DCA curves. TNM: Tumor-node-metastasis; RSF: Random survival forest; CoxPH: Cox proportional hazards.

Citation: Liu W, Wu HY, Lin JX, Qu ST, Gu YJ, Zhu JZ, Xu CF. Combining lymph node ratio to develop prognostic models for postoperative gastric neuroendocrine neoplasm patients. World J Gastrointest Oncol 2024; 16(8): 3507-3520
URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3507.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3507